|
USP16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.82707232360735E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.220000E-01 |
| Stage1-vs-Stage3 |
6.684200E-03 |
| Stage1-vs-Stage4 |
1.14689999997086E-06 |
| Stage2-vs-Stage3 |
8.942900E-03 |
| Stage2-vs-Stage4 |
1.417620E-04 |
| Stage3-vs-Stage4 |
5.901900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.86070048258102E-10 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
2.500000E-01 |
| Caucasian-vs-Asian |
4.291400E-01 |
| AfricanAmerican-vs-Asian |
6.563200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.744000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.08589999997722E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.109800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.896000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.267600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.979800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.874200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.249200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.65399999999738E-05 |
| Classical-VS-Follicular |
2.033900E-04 |
| Classical-VS-Other |
3.553400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.48220002937904E-09 |
| Tall-VS-Other |
3.248400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.611800E-02 |
| Follicular-VS-Normal |
2.42006414907792E-12 |
| Other-VS-Normal |
1.00279999970532E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.096000E-03 |
|
|
